Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022

BUY
$0.23 - $14.18 $1,233 - $76,033
5,362 Added 20.67%
31,307 $7,000
Q2 2022

Aug 09, 2022

SELL
$0.24 - $0.42 $3,431 - $6,004
-14,297 Reduced 35.53%
25,945 $9,000
Q1 2022

May 17, 2022

SELL
$0.33 - $0.56 $48,846 - $82,890
-148,019 Reduced 78.62%
40,242 $14,000
Q4 2021

Feb 17, 2022

SELL
$0.43 - $0.69 $30,622 - $49,139
-71,216 Reduced 27.45%
188,261 $84,000
Q3 2021

Nov 12, 2021

BUY
$0.58 - $0.84 $112,532 - $162,977
194,021 Added 296.41%
259,477 $165,000
Q2 2021

Sep 17, 2021

BUY
$0.6 - $0.89 $26,724 - $39,640
44,540 Added 212.95%
65,456 $46,000
Q1 2021

May 19, 2021

SELL
$0.52 - $1.52 $74,756 - $218,519
-143,763 Reduced 87.3%
20,916 $19,000
Q4 2020

Feb 24, 2021

SELL
$0.39 - $0.6 $40,494 - $62,298
-103,831 Reduced 38.67%
164,679 $74,000
Q3 2020

Dec 11, 2020

BUY
$0.56 - $1.49 $150,365 - $400,079
268,510 New
268,510 $154,000
Q2 2020

Aug 07, 2020

SELL
$0.39 - $0.83 $38,571 - $82,088
-98,902 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$0.42 - $0.62 $26,709 - $39,427
63,593 Added 180.1%
98,902 $52,000
Q3 2019

Nov 20, 2019

SELL
$0.36 - $0.64 $14,506 - $25,790
-40,297 Reduced 53.3%
35,309 $19,000
Q2 2019

Aug 13, 2019

BUY
$0.46 - $0.6 $28,570 - $37,266
62,110 Added 460.21%
75,606 $37,000
Q1 2019

Apr 12, 2019

SELL
$0.57 - $1.05 $71,100 - $130,973
-124,737 Reduced 90.24%
13,496 $8,000
Q4 2018

Jan 16, 2019

BUY
$0.78 - $3.57 $80,726 - $369,480
103,496 Added 297.94%
138,233 $119,000
Q3 2018

Nov 13, 2018

BUY
$0.38 - $1.42 $13,200 - $49,326
34,737 New
34,737 $40,000
Q2 2018

Jul 30, 2018

SELL
$1.16 - $2.0 $69,768 - $120,290
-60,145 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$1.16 - $2.0 $57,382 - $98,936
49,468 Added 463.31%
60,145 $83,000
Q1 2018

May 14, 2018

BUY
$1.6 - $3.17 $17,083 - $33,846
10,677 New
10,677 $19,000

Others Institutions Holding OGEN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About ORAGENICS INC


  • Ticker OGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 116,395,000
  • Market Cap $36.1M
  • Description
  • Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...
More about OGEN
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.